(Q33995028)

30 July 2017

1 reference

29 October 2020

1 reference

A systematic review of treatment guidelines for metastatic colorectal cancer (English)

1 reference

30 July 2017

1 reference

27 September 2019

1 reference

29 October 2020

1 reference

29 October 2020

1 reference

1 reference

metastatic colon cancer

1 reference

1 reference

M S Edwards

1

1 reference

30 July 2017

S D Chadda

2

1 reference

30 July 2017

Z Zhao

3

1 reference

30 July 2017

B L Barber

4

1 reference

30 July 2017

D P Sykes

5

1 reference

30 July 2017

1 February 2012

7 references

30 July 2017

21 March 2019

3 April 2019

27 September 2019

27 November 2019

13 December 2019

29 October 2020

7 references

30 July 2017

21 March 2019

3 April 2019

27 September 2019

27 November 2019

13 December 2019

29 October 2020

14

1 reference

30 July 2017

2

1 reference

30 July 2017

e31-47

1 reference

Creative Commons Attribution 2.5 Generic

30 July 2017

6 references

21 March 2019

3 April 2019

27 September 2019

27 November 2019

13 December 2019

on focus list of Wikimedia project

29 October 2020

ScienceSource

0 references

cites work

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

NCCN Clinical Practice Guidelines in Oncology: colon cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Anti-angiogenic therapies for metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Guidelines for the detection and treatment of liver metastases of colorectal cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

An international, multidisciplinary approach to the management of advanced colorectal cancer. International Working Group in Colorectal Cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562494

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of rectal cancer

5 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2011.02765.X

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2011.02765.X

Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2011.02765.X

Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2011.02765.X

Selection of patients for resection of hepatic colorectal metastases: expert consensus statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1318.2011.02765.X

Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

21 January 2018

1 reference

12 December 2020

Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates

1 reference

12 December 2020

NCCN Clinical Practice Guidelines in Oncology: rectal cancer

1 reference

12 December 2020

Improving resectability of hepatic colorectal metastases: expert consensus statement

1 reference

12 December 2020

Practice parameters for colon cancer

1 reference

12 December 2020

Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy

1 reference

12 December 2020

Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy

1 reference

12 December 2020

10.1111/J.1463-1318.2011.02765.X

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference